Collagen Solutions company

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics.
Our capabilities include the provision of native, soluble and powdered collagen formulations and expertise in the development and contract manufacture of collagen components for use as tissue scaffolds and medical devices.
Collagen Solutions' unique offering extends beyond material supply and contract services as our highly skilled staff support customers through various stages of development and regulatory approval, establishing long-term commercial relationships.

Funding Status: IPO
Industry: Regenerative Medicine
Estimated Revenue: $1M to $10M
Technology: P4 Medicine
Number Of Exists: Post-IPO Equity
Headquarters: London, England, United Kingdom
Total Funding: £18M
Last Funding Type: Post-IPO Equity
Investor Type: Company
Employee Number: 11-50
Investors Number: 2
Investment Stage: N/A
Founded Date: 7-4